Focus on healthcare innovators and established care models

Our capabilities and global platform are unique to the mid-market. With significant experience and deep relationships with corporates and financial sponsors investing in multiple sub-sectors, we are able to deliver tailored and focused advice to clients.

Sub–sectors

Our global Healthcare team has extensive experience across a broad range of healthcare sub-sectors, with a track record in delivering results for clients, anywhere in the world.

  • Care & services
  • Healthcare IT & supply chain
  • Medtech & life sciences
  • Pharma
Italy
Healthcare
Advised
  • Gada Group
on its acquisition of
  • Evoluzione
United States
Healthcare
Advised
  • Home Care Pulse
on its significant growth investment from
  • Cressey & Company
Japan
Healthcare
Advised
  • T Capital Partners
on its acquisition of
  • MicroBiopharm Japan
United Kingdom
Healthcare
Advised
  • Palamon Capital Partners
on its acquisition of
  • IDH Group
Japan
Healthcare
Advised
  • Biofermin Pharmaceutical Co Ltd
on its sale to
  • Taisho Pharmaceutical Holdings Co Ltd
Value: ¥14.1bn
Japan
Healthcare
Advised
  • Medley
on its capital and business alliance with
  • NTT DOCOMO
United States
Healthcare
Advised
  • Real Time Medical Systems
on its growth equity investment
Japan
Healthcare
Advised
  • MBK Partners
on its tender offer for shares of
  • Tsukui Holdings
United Kingdom
Healthcare
Advised
  • ICG
on its investment in
  • Lucid Group
Japan
Healthcare
Advised
  • UNIMAT Retirement Community
on the sale of a 50% stake to
  • UNIMAT Life Corporation
United Kingdom
Healthcare
Advised
  • NorthEdge Capital
on the acquisition of
  • Helios Medical Communications
Italy
Healthcare
Advised
  • Theras Group
on its international expansion
Japan
Industrials
Advised
  • Sumitomo Bakelite Co., Ltd.
on its acquisition of remaining 76.95% stake in
  • Kawasumi Laboratories, Inc.
Value: ¥27bn
United States
Education
Advised
  • TrueLearn
on a majority investment from
  • LLR Partners
Japan
Healthcare
Advised
  • Matsumoto kiyoshi Holdings
on the acquisition of a minority stake in
  • Cocokara Fine Inc.
Value: $353m
Japan
Healthcare
Advised
  • Nippon Sangyo Suishin Kiko
on the sale of
  • Vati Co., Ltd

For important information regarding transactions, please see our disclaimer.

I would like to thank DC Advisory for a job well done! Their structured advice throughout the process, along with a deep strategic insight into the potential buyers, was critical in bringing this deal to a successful close.

Xavier Houy, Corporate Director M&A, Head of Divestments, Sanofi

For important information regarding testimonials, please see our disclaimer.

UK Reportage 0125

Solutions

Delivering tailored and impactful solutions, DC Advisory leverages product experts across multiple markets – combining M&A, debt, coverage and specific capital raising expertise.

Select solution
Back to top

Your briefcase is empty

You can save PDFs to download our deal announcements and team profiles.

Briefcase
Category
Information
Actions
    The item(s) added to the briefcase may be lost if this browser is closed.